Apogee Therapeutics, Inc. (APGE) Earnings History
Annual and quarterly earnings data from 2022 to 2025
Loading earnings history...
APGE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
APGE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export APGE earnings history in CSV or JSON format
Free sign-in required to download data
Apogee Therapeutics, Inc. (APGE) Earnings Overview
As of May 8, 2026, Apogee Therapeutics, Inc. (APGE) reported trailing twelve-month net income of -$256M, reflecting -27.9% year-over-year growth. The company earned $-4.22 per diluted share over the past four quarters.
Looking at the long-term picture, APGE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$40M in fiscal 2022.
Apogee Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including REGN ($4.42B net income, 31.4% margin), ACLX (-$229M net income, -1027.3% margin), RXRX (-$560M net income, -863.4% margin), APGE has comparable earnings metrics. Compare APGE vs REGN →
APGE Earnings vs Peers
Earnings metrics vs comparable public companies
APGE Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$256M | -40.5% | -$286M | $-4.22 | - | - |
| 2024 | -$182M | -116.9% | -$217M | $-3.30 | - | - |
| 2023 | -$84M | -111.1% | -$93M | $-1.66 | - | - |
| 2022 | -$40M | - | -$31M | $-0.79 | - | - |
See APGE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs APGE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare APGE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAPGE — Frequently Asked Questions
Quick answers to the most common questions about buying APGE stock.
Is APGE growing earnings?
APGE EPS fell to $-4.22, with earnings declining -27.9%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-256M.
What are APGE's profit margins?
Apogee Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are APGE's earnings?
APGE earnings data spans 2022-2025. The declining earnings trend is -27.9% YoY. Historical data enables comparison across business cycles.